Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Ned Tijdschr Geneeskd ; 147(1): 32-5, 2003 Jan 04.
Article in Dutch | MEDLINE | ID: mdl-12564296

ABSTRACT

In two patients, men aged 80 and 75 years with cognitive deterioration, hallucinations and parkinsonism, the clinical diagnosis 'dementia with Lewy bodies' was established. Treatment with an atypical antipsychotic, risperidone and olanzapine respectively, resulted in an exacerbation of the parkinsonism. Rivastigmine evidently improved the psychosis, the anxiety and the cognitive, mood and behaviour disorders. Titrated treatment with levodopa improved the mobility without an increase of the psychosis. The treatment of dementia with Lewy bodies is complex. Levodopa can lead to an increase in visual hallucinations. Antipsychotics often cause serious side effects, such as increasing parkinsonism, sedation and cognitive deterioration. Cholinesterase inhibitors such as rivastigmine could possibly provide an alternative treatment for the neuropsychiatric symptoms.


Subject(s)
Carbamates/therapeutic use , Cholinesterase Inhibitors/therapeutic use , Lewy Body Disease/drug therapy , Neuroprotective Agents/therapeutic use , Phenylcarbamates , Pirenzepine/analogs & derivatives , Aged , Aged, 80 and over , Antiparkinson Agents/therapeutic use , Antipsychotic Agents/adverse effects , Antipsychotic Agents/therapeutic use , Benzodiazepines , Drug Therapy, Combination , Humans , Levodopa/therapeutic use , Lewy Body Disease/psychology , Male , Olanzapine , Pirenzepine/adverse effects , Pirenzepine/therapeutic use , Risperidone/adverse effects , Risperidone/therapeutic use , Rivastigmine , Treatment Outcome
SELECTION OF CITATIONS
SEARCH DETAIL
...